inibidores do vírus sincicial respiratório
compostos da formula (i), em que z1 é nr1a, chr1a ou cr1br1b; um dentre z2 e z3 é ch ou cr1a?, o outro é n, ch ou cr1a?; n é 0, 1 ou 2; q é 0, 1 ou 2; r1a, r1a?, r1b, r2 e r3 são conforme definido neste documento, seu uso como inibidores do vsr e aspectos relacionados. Compounds of Formula (I): (For...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | por |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | GENNADIY KALAYANOV JOHAN BYLUND CHRISTIAN BROCHU CLAUDIO STURINO MEGAN BERTRAND LOURDES SALVADOR ODEN HANS WESTERLIND MARIE LEIJONMARCK CYRILLE KUHN SUSANA AYESA ELISE GHIRO FERNANDO SEHGELMEBLE HORST WÄHLING KAROLINA ERSMARK |
| description | compostos da formula (i), em que z1 é nr1a, chr1a ou cr1br1b; um dentre z2 e z3 é ch ou cr1a?, o outro é n, ch ou cr1a?; n é 0, 1 ou 2; q é 0, 1 ou 2; r1a, r1a?, r1b, r2 e r3 são conforme definido neste documento, seu uso como inibidores do vsr e aspectos relacionados.
Compounds of Formula (I): (Formula I), wherein Z1 is NR1A, CHR1A or CR1BR1B; one of Z2 and Z3 is CH or CR1A', the other is N, CH or CR1A'; n is 0, 1 or 2; q is 0, 1 or 2; R1A, R1A', R1B, R2 and R3 are as defined herein, their use as inhibitors of RSV and related aspects. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_BR112018001726A2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>BR112018001726A2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_BR112018001726A23</originalsourceid><addsrcrecordid>eNrjZNDJzMtMykzJL0otVkjJVyg7vLaotFihODMvOTM5MzFHAShekFmUWHJ4c1FmPg8Da1piTnEqL5TmZlB1cw1x9tBNLciPBypMTE7NSy2JdwoyNDQyMLQwMDA0NzJzNDImVh0ArvYtMw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>inibidores do vírus sincicial respiratório</title><source>esp@cenet</source><creator>GENNADIY KALAYANOV ; JOHAN BYLUND ; CHRISTIAN BROCHU ; CLAUDIO STURINO ; MEGAN BERTRAND ; LOURDES SALVADOR ODEN ; HANS WESTERLIND ; MARIE LEIJONMARCK ; CYRILLE KUHN ; SUSANA AYESA ; ELISE GHIRO ; FERNANDO SEHGELMEBLE ; HORST WÄHLING ; KAROLINA ERSMARK</creator><creatorcontrib>GENNADIY KALAYANOV ; JOHAN BYLUND ; CHRISTIAN BROCHU ; CLAUDIO STURINO ; MEGAN BERTRAND ; LOURDES SALVADOR ODEN ; HANS WESTERLIND ; MARIE LEIJONMARCK ; CYRILLE KUHN ; SUSANA AYESA ; ELISE GHIRO ; FERNANDO SEHGELMEBLE ; HORST WÄHLING ; KAROLINA ERSMARK</creatorcontrib><description>compostos da formula (i), em que z1 é nr1a, chr1a ou cr1br1b; um dentre z2 e z3 é ch ou cr1a?, o outro é n, ch ou cr1a?; n é 0, 1 ou 2; q é 0, 1 ou 2; r1a, r1a?, r1b, r2 e r3 são conforme definido neste documento, seu uso como inibidores do vsr e aspectos relacionados.
Compounds of Formula (I): (Formula I), wherein Z1 is NR1A, CHR1A or CR1BR1B; one of Z2 and Z3 is CH or CR1A', the other is N, CH or CR1A'; n is 0, 1 or 2; q is 0, 1 or 2; R1A, R1A', R1B, R2 and R3 are as defined herein, their use as inhibitors of RSV and related aspects.</description><language>por</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2018</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180918&DB=EPODOC&CC=BR&NR=112018001726A2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180918&DB=EPODOC&CC=BR&NR=112018001726A2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>GENNADIY KALAYANOV</creatorcontrib><creatorcontrib>JOHAN BYLUND</creatorcontrib><creatorcontrib>CHRISTIAN BROCHU</creatorcontrib><creatorcontrib>CLAUDIO STURINO</creatorcontrib><creatorcontrib>MEGAN BERTRAND</creatorcontrib><creatorcontrib>LOURDES SALVADOR ODEN</creatorcontrib><creatorcontrib>HANS WESTERLIND</creatorcontrib><creatorcontrib>MARIE LEIJONMARCK</creatorcontrib><creatorcontrib>CYRILLE KUHN</creatorcontrib><creatorcontrib>SUSANA AYESA</creatorcontrib><creatorcontrib>ELISE GHIRO</creatorcontrib><creatorcontrib>FERNANDO SEHGELMEBLE</creatorcontrib><creatorcontrib>HORST WÄHLING</creatorcontrib><creatorcontrib>KAROLINA ERSMARK</creatorcontrib><title>inibidores do vírus sincicial respiratório</title><description>compostos da formula (i), em que z1 é nr1a, chr1a ou cr1br1b; um dentre z2 e z3 é ch ou cr1a?, o outro é n, ch ou cr1a?; n é 0, 1 ou 2; q é 0, 1 ou 2; r1a, r1a?, r1b, r2 e r3 são conforme definido neste documento, seu uso como inibidores do vsr e aspectos relacionados.
Compounds of Formula (I): (Formula I), wherein Z1 is NR1A, CHR1A or CR1BR1B; one of Z2 and Z3 is CH or CR1A', the other is N, CH or CR1A'; n is 0, 1 or 2; q is 0, 1 or 2; R1A, R1A', R1B, R2 and R3 are as defined herein, their use as inhibitors of RSV and related aspects.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2018</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNDJzMtMykzJL0otVkjJVyg7vLaotFihODMvOTM5MzFHAShekFmUWHJ4c1FmPg8Da1piTnEqL5TmZlB1cw1x9tBNLciPBypMTE7NSy2JdwoyNDQyMLQwMDA0NzJzNDImVh0ArvYtMw</recordid><startdate>20180918</startdate><enddate>20180918</enddate><creator>GENNADIY KALAYANOV</creator><creator>JOHAN BYLUND</creator><creator>CHRISTIAN BROCHU</creator><creator>CLAUDIO STURINO</creator><creator>MEGAN BERTRAND</creator><creator>LOURDES SALVADOR ODEN</creator><creator>HANS WESTERLIND</creator><creator>MARIE LEIJONMARCK</creator><creator>CYRILLE KUHN</creator><creator>SUSANA AYESA</creator><creator>ELISE GHIRO</creator><creator>FERNANDO SEHGELMEBLE</creator><creator>HORST WÄHLING</creator><creator>KAROLINA ERSMARK</creator><scope>EVB</scope></search><sort><creationdate>20180918</creationdate><title>inibidores do vírus sincicial respiratório</title><author>GENNADIY KALAYANOV ; JOHAN BYLUND ; CHRISTIAN BROCHU ; CLAUDIO STURINO ; MEGAN BERTRAND ; LOURDES SALVADOR ODEN ; HANS WESTERLIND ; MARIE LEIJONMARCK ; CYRILLE KUHN ; SUSANA AYESA ; ELISE GHIRO ; FERNANDO SEHGELMEBLE ; HORST WÄHLING ; KAROLINA ERSMARK</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_BR112018001726A23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>por</language><creationdate>2018</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>GENNADIY KALAYANOV</creatorcontrib><creatorcontrib>JOHAN BYLUND</creatorcontrib><creatorcontrib>CHRISTIAN BROCHU</creatorcontrib><creatorcontrib>CLAUDIO STURINO</creatorcontrib><creatorcontrib>MEGAN BERTRAND</creatorcontrib><creatorcontrib>LOURDES SALVADOR ODEN</creatorcontrib><creatorcontrib>HANS WESTERLIND</creatorcontrib><creatorcontrib>MARIE LEIJONMARCK</creatorcontrib><creatorcontrib>CYRILLE KUHN</creatorcontrib><creatorcontrib>SUSANA AYESA</creatorcontrib><creatorcontrib>ELISE GHIRO</creatorcontrib><creatorcontrib>FERNANDO SEHGELMEBLE</creatorcontrib><creatorcontrib>HORST WÄHLING</creatorcontrib><creatorcontrib>KAROLINA ERSMARK</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>GENNADIY KALAYANOV</au><au>JOHAN BYLUND</au><au>CHRISTIAN BROCHU</au><au>CLAUDIO STURINO</au><au>MEGAN BERTRAND</au><au>LOURDES SALVADOR ODEN</au><au>HANS WESTERLIND</au><au>MARIE LEIJONMARCK</au><au>CYRILLE KUHN</au><au>SUSANA AYESA</au><au>ELISE GHIRO</au><au>FERNANDO SEHGELMEBLE</au><au>HORST WÄHLING</au><au>KAROLINA ERSMARK</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>inibidores do vírus sincicial respiratório</title><date>2018-09-18</date><risdate>2018</risdate><abstract>compostos da formula (i), em que z1 é nr1a, chr1a ou cr1br1b; um dentre z2 e z3 é ch ou cr1a?, o outro é n, ch ou cr1a?; n é 0, 1 ou 2; q é 0, 1 ou 2; r1a, r1a?, r1b, r2 e r3 são conforme definido neste documento, seu uso como inibidores do vsr e aspectos relacionados.
Compounds of Formula (I): (Formula I), wherein Z1 is NR1A, CHR1A or CR1BR1B; one of Z2 and Z3 is CH or CR1A', the other is N, CH or CR1A'; n is 0, 1 or 2; q is 0, 1 or 2; R1A, R1A', R1B, R2 and R3 are as defined herein, their use as inhibitors of RSV and related aspects.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | por |
| recordid | cdi_epo_espacenet_BR112018001726A2 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | inibidores do vírus sincicial respiratório |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T22%3A08%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=GENNADIY%20KALAYANOV&rft.date=2018-09-18&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EBR112018001726A2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |